IOT Stock Overview
Innovotech Inc. offers assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Innovotech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.13 |
| 52 Week High | CA$0.15 |
| 52 Week Low | CA$0.02 |
| Beta | 0.86 |
| 1 Month Change | 52.94% |
| 3 Month Change | 30.00% |
| 1 Year Change | -13.33% |
| 3 Year Change | -13.33% |
| 5 Year Change | 136.36% |
| Change since IPO | -38.10% |
Recent News & Updates
Shareholder Returns
| IOT | CA Life Sciences | CA Market | |
|---|---|---|---|
| 7D | 0% | 4.1% | 0.7% |
| 1Y | -13.3% | 4.7% | 5.5% |
Return vs Industry: IOT underperformed the Canadian Life Sciences industry which returned 5.2% over the past year.
Return vs Market: IOT underperformed the Canadian Market which returned 6.1% over the past year.
Price Volatility
| IOT volatility | |
|---|---|
| IOT Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 6.9% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: IOT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine IOT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Craig Milne | innovotech.ca |
Innovotech Inc. offers assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.
Innovotech Inc. Fundamentals Summary
| IOT fundamental statistics | |
|---|---|
| Market cap | CA$5.07m |
| Earnings (TTM) | -CA$211.06k |
| Revenue (TTM) | CA$1.09m |
4.6x
P/S Ratio-24.0x
P/E RatioIs IOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IOT income statement (TTM) | |
|---|---|
| Revenue | CA$1.09m |
| Cost of Revenue | CA$353.61k |
| Gross Profit | CA$736.97k |
| Other Expenses | CA$948.03k |
| Earnings | -CA$211.06k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0054 |
| Gross Margin | 67.58% |
| Net Profit Margin | -19.35% |
| Debt/Equity Ratio | 0% |
How did IOT perform over the long term?
See historical performance and comparison